EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Diagnostic yield of clinical exome sequencing in patients with suspected hereditary neuropathy

Can Ebru Bekircan-Kurt iD, Doruk Arslan iD, Naz Güleray iD, Sevim Erdem-Özdamar iD, Burcu Balci-Hayta iD, Ersin Tan iD

Turkish Journal of Medical Sciences · 12.12.2025 · 55 (6) · 1475-1479

DOI: 10.55730/1300-0144.6105 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Turkish Journal of Medical Sciences, online erschienen am 12.12.2025. Verfasst von Can Ebru Bekircan-Kurt und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, School of Medicine, Hacettepe University, Ankara, Turkiye. Hauptthemen laut MEDLINE: Exome Sequencing. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/aim: Hereditary neuropathies exhibit significant genetic heterogeneities, often making molecular diagnosis challenging. Clinical Exome Sequencing (CES) allows the simultaneous evaluation of a wide range of candidate genes, and can be considered an efficient approach to identifying underlying genetic causes. The present study assesses the diagnostic utility of CES in patients with clinically suspected hereditary neuropathy. Materials and methods: Included in the study were 21 patients with clinically suspected hereditary neuropathy who underwent CES. DNA samples were isolated from peripheral blood and subjected to CES on an Illumina NextSeq 2000 system, while a bioinformatics analysis and variant interpretation were performed using Sophia DDM® software. All identified variants were classified according to the most recent American College of Medical Genetics and Genomics (ACMG) guidelines.

Results

Pathogenic or likely pathogenic variants were identified in seven patients (33.3%), of whom six (28.5%) had a confirmed molecular diagnosis consistent with the clinical phenotype. Variants of uncertain significance (VUS) were detected in nine patients (42.8%), while no clinically relevant variants were found in five (23.8%).

Conclusion

CES contributed significantly to the establishment of molecular diagnoses in nearly one-third of the studied cohort. However, the high prevalence of VUS underscores the limitations of current interpretation frameworks, revealing a need for functional validation and familial segregation analyses. Despite these challenges, CES remains a valuable and appropriate diagnostic tool, particularly in resource-limited healthcare settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Exome SequencingHumansFemaleMaleAdultMiddle AgedAdolescentChildYoung AdultGenetic Testing

Stichwörter der Autor:innen

Clinical exome sequencingdiagnostic utilityhereditary neuropathies

Autor:innen und Institutionen

  • Department of Neurology, School of Medicine, Hacettepe University, Ankara, Turkiye.
  • Department of Neurology, Sincan Research and Training Hospital, Ankara, Turkiye.
  • Department of Medical Genetics, School of Medicine, Hacettepe University, Ankara, Turkiye.
  • Department of Medical Biology, School of Medicine, Hacettepe University, Ankara, Turkiye.

ORCID-Profile: Can Ebru Bekircan-Kurt, Doruk Arslan, Naz Güleray, Sevim Erdem-Özdamar, Burcu Balci-Hayta, Ersin Tan

Zitieren

APA

Bekircan-Kurt, C. E., Arslan, D., Güleray, N., Erdem-Özdamar, S., Balci-Hayta, B., & Tan, E. (2025). Diagnostic yield of clinical exome sequencing in patients with suspected hereditary neuropathy. Turkish Journal of Medical Sciences, 55(6), 1475-1479. https://doi.org/10.55730/1300-0144.6105

Vancouver

Bekircan-Kurt CE, Arslan D, Güleray N, Erdem-Özdamar S, Balci-Hayta B, Tan E. Diagnostic yield of clinical exome sequencing in patients with suspected hereditary neuropathy. Turkish Journal of Medical Sciences. 2025;55(6):1475-1479. doi:10.55730/1300-0144.6105

BibTeX
@article{BekircanKurt2025,
  author = {Bekircan-Kurt, Can Ebru and Arslan, Doruk and Güleray, Naz and Erdem-Özdamar, Sevim and Balci-Hayta, Burcu and Tan, Ersin},
  title = {Diagnostic yield of clinical exome sequencing in patients with suspected hereditary neuropathy},
  journal = {Turkish Journal of Medical Sciences},
  year = {2025},
  volume = {55},
  number = {6},
  pages = {1475--1479},
  doi = {10.55730/1300-0144.6105}
}
Kostenlos starten →